Illinois TOOL Works Inc

Identity and listing

Scale and organisation

Market data

Illinois Tool Works is a 114-year-old, Glenview-based multi-industrial manufacturer with $16.0 billion of FY2025 revenue across seven segments:

• Automotive OEM

• Food Equipment

• Test & Measurement and Electronics

• Welding

• Polymers & Fluids

• Construction Products

• Specialty Products

ITW does not compete on scale or vertical integration. Its edge is a proprietary operating system, the "ITW Business Model," built on three elements:

• 80/20 Front-to-Back management, which concentrates resources on the largest, most profitable customers and products.

• Customer-Back Innovation (CBI), which develops products from customer pain points rather than from a central R&D lab.

A decentralised, entrepreneurial culture: of 88 scaled-up divisions.

Since launching its Enterprise Strategy in late 2012, ITW has lifted operating margin from 15.9% to 26.3% and after-tax ROIC from 14.5% to 29.3%. It has done this while shrinking revenue through divestiture of commoditised businesses (2026 Proxy). The "Next Phase" (2024–2030) pivots the agenda from margin expansion to sustained 4%+ organic growth, powered by a 3%+ CBI revenue yield. ITW is a Dividend King, with 63 consecutive annual dividend increases.

Company's own description (Form 10-K FY2025, paraphrased)

ITW describes itself as a global manufacturer of a diversified range of industrial products and equipment, organised into 88 divisions operating in 49 countries. Its seven reportable segments are grouped by similar product offerings and end markets. Products are distributed mainly direct to industrial manufacturers and through independent distributors.

Backlog is not considered significant because delivery periods are short and inventory turns quickly. The company names its core competitive advantage as the ITW Business Model:

• 80/20 Front-to-Back process

• Customer-Back Innovation

• Decentralised entrepreneurial culture

Primary raw materials are steel, resins and chemicals, sourced from numerous commercial suppliers.

Business model

ITW's model rests on niche leadership in fragmented, technically demanding markets. Its businesses typically hold strong positions in specialised applications where:

• the product is a small share of the customer's total cost but critical to performance (e.g., an automotive fastener, a weld wire, a test frame); and

• differentiation comes from engineering, application know-how, brand and service.

The 80/20 discipline continually prunes low-value SKUs and customers through Product Line Simplification (PLS). PLS deliberately reduced organic revenue by about 60 basis points in FY2024, about 60 bps in FY2025, and about 60 bps in H1 FY2026, in exchange for structurally higher margins (10-K FY2025; 10-Q Q2 FY2026).

Revenue model mix. ITW does not report a formal product/service/subscription split. The analyst characterisation is:

Value-chain position

ITW sits as a Tier-1/Tier-2 component supplier (Automotive OEM, Specialty appliance components) and as an OEM of branded equipment and consumables (Welding, Food Equipment, Test & Measurement, Construction Products, Polymers & Fluids).

It typically manufactures "in the market, for the market." This localisation was cited in FY2025 as the reason ITW could largely offset U.S. tariff costs through pricing and supply-chain actions (FY2025 release; 10-K FY2025).

Customer types and end markets

Independent characterisation

ITW is best understood as a portfolio of about 88 mid-sized, high-return niche franchises bound together by a common management system. Corporate allocates capital. Divisions run the business.

Strengths of this structure:

• A low-capital-intensity, cash-generative model. Capex was 2.6% of revenue in FY2025 ($419M on $16,044M), and after-tax ROIC is about 29–31%.

• Demand is diversified across consumer, industrial and capex cycles.

Weaknesses of this structure:

• Organic growth has historically been modest (FY2023–FY2025 averaged roughly 0–2%).

• PLS creates a built-in headwind to reported growth.

• The company has unusually high exposure to Detroit-3 and European auto content, short-cycle construction, and the semiconductor capex cycle.

The FY2026 data, with Q2 organic growth of +4.5% and double-digit growth in Welding and Test & Measurement, is the first meaningful evidence that the CBI-driven growth pivot may be gaining traction.

Stated corporate strategy themes (10-K FY2025; 2026 Proxy)

The ITW Business Model is the company's core source of value creation and competitive advantage. It has three elements:

1. 80/20 Front-to-Back: a proprietary, data-driven operating system that focuses each business on its "80" (the largest and best customers and products) and removes the cost and complexity of the "20."

2. Customer-Back Innovation (CBI): innovation that starts from key customers' pain points, led by divisions rather than a central R&D centre.

3. Decentralised, entrepreneurial culture: "flexibility within the framework."

Enterprise Strategy, 2012–2023 (completed). Four pillars:

Portfolio management: exit commoditised businesses.

Business structure simplification: scaled up to 88 divisions.

Strategic sourcing: an average 1% annual spend reduction since 2013.

80/20 re-application: Outcome: operating margin rose from 15.9% (2012) to 26.3% (2025), and after-tax ROIC from 14.5% to 29.3%.

Next Phase, 2024–2030. The organising goal is to make high-quality, above-market organic growth a defining ITW strength, on par with operational excellence. Organic growth of 4%+ through the cycle is the highest priority.

2030 performance goals and the Core TSR Model

Explicitly stated in the 2026 Proxy / 10-K:

• Organic growth of 4%+ through the cycle.

• CBI yield of 3%+ per year by 2030 (2.0% in FY2024; 2.4% in FY2025, "more than double historical levels").

• After-tax ROIC continuing above 30% (the full-year FY2026 target is above 30%, per the Q2 FY2026 summary).

• Operating margin of about 30% by 2030.

• Free cash flow conversion of 100%+.

• High-single-digit to low-double-digit EPS growth within a "Core TSR Model."

Strategic initiatives, last 24 months (Oct 2024 – Oct 2026)

Management guidance, FY2026 (as of Q2 FY2026, 28 Jul 2026)

Management expects all seven segments to grow organically and expand margins in FY2026.

Disclosure note:

• ITW does not publish SKU-level pricing, launch dates or product-level revenue.

• Brand names below combine the 10-K "significant trademarks" (Deltar, Shakeproof, Hobart, Instron, MTS, Miller, Rain-X, Permatex, Paslode, Hi-Cone) with long-standing ITW division brands. Those not confirmed in the 10-K are marked (division brand, not 10-K-listed).

• Pricing model for all lines: transactional unit/volume pricing via direct or distributor channels. Contractual pricing applies with auto OEMs. Service is sold on a contract or time-and-materials basis. No specific prices are disclosed.

Automotive OEM

Launch year / latest version: not publicly disclosed. ITW cites higher content per vehicle with Detroit-3 OEMs and foreign OEMs in China (10-K FY2025).

Food Equipment

Test & Measurement and Electronics

Welding

Polymers & Fluids

Construction Products

Specialty Products

Sources:

• FY2025 and FY2024 releases and 10-K FY2025 (FY2023–FY2025)

• FY2022 release (FY2021–FY2022)

• Depreciation from XBRL-derived 10-K data

EBITDA is defined by the analyst as operating income plus depreciation plus amortisation and impairment of intangibles. It excludes non-operating "other income."

Income statement

Adjusted EPS notes: FY2022 excludes $0.60 of divestiture gains. FY2024 excludes $1.26 (Wilsonart gain) and $0.30 (LIFO change). FY2021, FY2023 and FY2025 have no adjustment.

Margins and growth (%)

Table notes:

• FY2021 and FY2023 organic growth were not captured in the sources reviewed.

• FY2024 operating margin was 26.1% excluding the LIFO benefit.

• FY2021–FY2025 revenue CAGR is 2.6% (derived). Diluted EPS CAGR is 5.4% (derived); adjusted EPS CAGR is 5.4%.

Balance sheet

Interim balance sheet data:

• At 31 Mar 2026: cash $827M and total debt $9.15bn (Q1 FY2026 release summary).

• At 30 Jun 2026: total debt/EBITDA was 2.0x (Q2 FY2026 call).

Cash flow

Table notes:

• Dividends paid are estimated as average basic shares × dividends paid per share. The 10-K states about $1.8bn for FY2025 and about $1.7bn for FY2024.

• FY2022–FY2025 are as reported.

• FY2024 FCF conversion was 94% on adjusted net income.

Returns, liquidity, leverage and efficiency ratios

All ratios except After-tax ROIC are derived by the analyst.

ROIC note: FY2024 was 30.3% excluding the LIFO benefit (2026 Proxy). FY2022 was 29.1% (FY2022 release).

Commentary on trends, inflections and drivers

Revenue: a deliberately "flat-but-better" top line.

• Revenue rose 10.2% in FY2022 on 12.1% organic growth, driven by post-COVID recovery and price.

• It then plateaued at about $16bn for three years. FY2023 grew +1.1%, FY2024 fell -1.3% (organic -0.7%), and FY2025 grew +0.9% (organic flat).

• Three forces explain the stagnation:

  • PLS, a self-inflicted headwind of about 60 bps per year;

  • cyclical weakness in U.S. residential construction (Construction organic -6.1% and -5.1%), semiconductors, and Detroit-3/European auto;

  • divestitures in FY2022–FY2023.

• FY2026 is the inflection year. Organic growth accelerated from +0.4% (Q1) to +4.5% (Q2), and full-year organic guidance was raised to about 3.5% at the midpoint (Q2 FY2026 release).

Margins: structural, initiative-driven expansion.

• Gross margin rose about 330 bps from FY2022 to FY2025, from 40.8% to 44.1%.

• Operating margin rose from 23.8% to 26.3%. Q2 FY2026 delivered 26.7%, the most profitable quarter in company history ($1.15bn operating income).

• Enterprise initiatives (80/20 Front-to-Back and strategic sourcing) contributed 130 bps in FY2024, 130 bps in FY2025, and about 120 bps per quarter in FY2026, independent of volume.

• The FY2025 decline from 26.8% to 26.3% is optical: it reflects the non-recurrence of the FY2024 LIFO benefit (70 bps). Underlying margin rose 20 bps despite flat volume and higher health and welfare costs.

Earnings quality.

• Reported EPS is noisy because of one-offs:

  • FY2022 divestiture gains ($0.60)

  • FY2024 Wilsonart gain ($1.26) and LIFO change ($0.30)

  • recurring discrete tax benefits (FY2021 UK rate change, $112M; FY2024 IP reorganisation, $87M; FY2025, $48M net)

• Adjusted EPS grew steadily: $9.17 → $9.74 → $10.15 → $10.49. The FY2026 guidance midpoint of $11.45 implies about 9% growth.

• Share count reduction contributes about 2 points per year of EPS growth (diluted shares fell from 316.4M to 292.3M, -7.6%, over FY2021–FY2025).

Balance sheet: deliberately lean equity.

• Book equity is only about $3.2bn after $26.9bn of cumulative treasury purchases. That makes ROE (about 95–105%) and debt/equity (about 2.8x) uninformative.

• The relevant leverage metric is net debt/EBITDA, which held in a 1.5–1.8x range. It rose to 1.76x in FY2025 as short-term debt increased (including the $1.0bn 2.65% note maturing 15 Nov 2026, now classified as current).

• Goodwill and intangibles ($5.7bn) are 35% of assets. Intangibles are amortising down: amortisation fell from $134M to $80M.

Cash flow.

• FY2022 FCF ($1.9bn; 64% conversion) was depressed by deliberate inventory builds to protect customer service amid supply-chain stress (DIO 79.5 days).

• FY2023 saw the release ($3.1bn FCF; 104% conversion).

• FY2025 conversion of 88% was below the >100% guidance, mainly on working capital: receivables rose $236M and DSO rose to 73 days.

• Q2 FY2026 FCF rose 41% year on year. Management guides FY2026 FCF conversion above 100%.

Capital returns. In FY2025 ITW returned $3.3bn (about 108% of net income) and invested about $0.8bn in growth and productivity (FY2025 release).

Management guidance and consensus

FY2026 guidance (28 Jul 2026): - Revenue growth of 4–5%, with organic growth of about 3.5% at the midpoint.

• Operating margin of 26.5–27.5%.

• GAAP EPS of $11.35–$11.55 (midpoint +9%).

• FCF conversion above 100%.

• About $1.5bn of buybacks.

Consensus: FY2026 EPS of about $11.45 matches the guidance midpoint. FY2027 consensus was not captured.

Long-term framework: 4%+ organic growth through the cycle and 3%+ CBI yield by 2030. ROIC continuing at or above 30% is stated.

Bull case

1. The growth pivot is real. Organic growth moved from 0.0% (FY2025) to +4.5% (Q2 FY2026), led by capex-cycle segments. Orders in Welding and Electronics are running ahead of revenue, and CBI yield rose 40 bps to 2.4%. If CBI reaches 3%+ while 80/20 adds about 100 bps of margin per year, a 9–10% EPS compounding path is credible.

2. Margin runway is intact. Enterprise initiatives contribute about 120–130 bps per year. Q2 FY2026's 26.7% margin came despite a 40 bps price/cost lag that management expects to reverse in H2. Construction Products is at 30.2% margin even at trough volumes and could deliver strong incremental margins when housing turns.

3. Capital returns are visible and defensive. The 7% dividend growth, the new $6bn buyback (about 7% of market cap), A1/A+ ratings, and ROIC near 30% support premium-quality status in volatile macro conditions.

Bear case

1. The valuation already discounts the pivot. At about 25–26× forward EPS versus a 10-year average of about 23×, ITW trades above many higher-growth peers. Several brokers rate it Underperform (Wolfe, Evercore), and consensus is "Hold."

2. Growth durability is unproven. Three years of flat organic growth preceded the 2026 bounce, and part of the bounce is cyclical (semiconductor and capex recovery). PLS, Detroit-3/European auto mix and U.S. housing remain structural drags. A capex relapse would expose the 4%+ goal.

3. Input-cost, FX and leverage creep. Resin and chemical inflation already dented Q2 margins. FX was a tailwind in FY2026 (Q1 +3.9%) and could reverse. Net debt/EBITDA has crept to about 1.8–2.0x with about $1.9bn of maturities by early 2027, while buybacks continue at about $1.5bn per year.

Key catalysts and monitorables (next 12 months)

Analyst verdict

Illinois Tool Works is among the highest-quality franchises in the global industrial universe.

The evidence of quality:

• Five consecutive years of after-tax ROIC near 30%.

• Operating margins expanding from 23.8% to 26.3% through a period of flat revenue.

• A record 26.7% quarterly margin in Q2 FY2026.

• A capital-light model converting most earnings into cash for a 63-year dividend-growth streak.

The 80/20 operating system is not a slogan. It has demonstrably delivered about 130 bps of annual margin improvement independent of the cycle. The decentralised structure also proved its resilience in 2025, when localised production allowed full tariff offset.

The investment debate has shifted from margins to growth. That is exactly where ITW's record is weakest. FY2024–FY2025 organic growth averaged about zero, against a 4%+ through-cycle objective. Product-line simplification is a deliberate brake, and end-market mix (Detroit-3 and European auto, U.S. housing) has been unhelpful.

FY2026 provides the first credible counter-evidence:

• Organic growth reached +4.5% in Q2.

• Electronics grew 21%.

• Welding grew double digits.

• Guidance has been raised twice.

• CBI yield climbed to 2.4%.

However, a meaningful part of this acceleration is cyclical recovery rather than proven structural share gain.

The balance of risk. At roughly 25× forward earnings and an EV/EBITDA near 19×, the shares already capitalise much of the pivot. The upside case requires two or three more quarters of 3–5% organic growth, a reversal of the resin-driven price/cost lag, and a credible FY2027 guide approaching the 4% target. Downside risk is cushioned by balance-sheet strength (A1/A+), the $6bn buyback and dividend support, but valuation de-rating is the dominant risk if capex momentum fades.

Overall assessment: high-quality compounder, fairly valued. It is suited to quality-focused and income-oriented portfolios. Q3 FY2026 (about 23 October) and the FY2027 guide (February 2027) are the decisive near-term tests of whether ITW can make above-market organic growth a "defining strength" to match its margins. A materially better entry point would likely require a pullback toward the low-to-mid-$260s (about 23× FY2026 EPS). This is not a recommendation to transact. Readers should consult a licensed financial adviser.

Litigation, regulatory and layoff items: * Item 3 of the FY2025 10-K reports no legal proceedings. Headcount drift (about 44,000 → about 43,000) reflects ongoing 80/20 restructuring.